Clinical TrialsSearch results
Number of results: 322
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression
- Sarcoma with c-kit or PDGFR expression by immunohistochemistry
- Office of Imatinib phase2 study
- 2005-08-22
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Recruiting
- Jumihaidokuto for acne vulgaris
- Acne vulgaris
- Nomoto Mayumi
- 2022-11-10
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Not yet recruiting
- A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants with Relapsed or Refractory Myeloma who Have Received an Anti-CD38 Antibody and Lenalidomide
- Relapsed or Refractory Multiple Myeloma
- Nishikawa Kazuko
- 2024-04-12
Other
- Nippon ICD Plus Pharmacologic Option Necessity
- patients with spontaneous episode(s) of sustained ventricular tachycardia or ventricular fibrillation associated with organic heart disease
- NIPPON Investigators
- 2006-04-01
Other
- The randomized trial about the efficacy of a 2-Day in-Hospital Diabetes Educational Program for prevention of type 2 diabetes (The JOETSU Diabetes Prevention Trial)
- Impared Glucose Tolerance
- Niigata-Rousai Hospital, Joetsu, Japan
- 2007-11-29